Align Technology Prevails in China Patent Infringement Action Against Angelalign
Align Technology said a Jinan Intermediate People’s Court issued a first-instance ruling on Aug. 10, 2026 in a China patent case against Angel. The court found Angel’s MasterForce and ATreat systems infringe Align’s CN113693748B patent and ordered Angel to stop use, manufacturing, and sales, awarding RMB 10 million in damages. Angel can appeal to China’s Supreme People’s Court.
How this was made
The 30-second read
Why it matters
A China first-instance infringement judgment adds incremental confirmation of Align’s patent strength for specific digital orthodontic workflow technologies, with an injunction and damages, but appeal overhang remains.
Market read
Traders may reassess ALGN’s IP enforcement momentum and the probability of sustained competitive pressure on Angel in China, while monitoring appeal outcomes.
What to watch
The article does not state whether the RMB 10m damages are collectible or whether the injunction is stayed during appeal, which can materially affect timing of any commercial impact.
Background
Align previously pursued Angel across multiple forums, including a UPC preliminary injunction and an ongoing ITC process for other patents.
Ticker impact
Jinan court ruled Angel’s MasterForce and ATreat systems infringe ALGN’s CN113693748B, ordering a China stop and RMB 10m damages.
Near-term positive bias for ALGN on IP-enforcement headlines; magnitude likely limited by appeal risk and absence of guidance/financial impact beyond RMB 10m.
The article discloses a specific first-instance infringement judgment, injunction to cease manufacturing/sales in China, and damages, but also notes the ruling is appealable and does not quantify broader revenue impact.
Market effects
Reinforces that digital orthodontics workflows and simulation/treatment-planning tech are enforceable IP targets, potentially raising perceived legal risk for competitors.
Highlights China as an active venue for orthodontic IP enforcement, which could affect competitive dynamics for aligner makers selling into China.
Adds to a multi-jurisdiction enforcement track record (UPC, ITC), which can influence how markets price ALGN’s long-run IP moat.
Counterpoint
Because the decision is appealable and only first-instance, the market may discount near-term impact on competitor sales and ALGN’s earnings.
Key entities
- companyAlign Technology
US-listed clear aligner and digital orthodontics company that filed the China patent infringement action and won first-instance judgment.
- companyAngelalign
Defendant in the China patent infringement action; may appeal to China’s Supreme People’s Court.
- courtJinan Intermediate People’s Court
Issued the first-instance judgment finding infringement and ordering cessation and damages.
- courtUnified Patent Court (UPC)
Previously issued and upheld a preliminary injunction on a different Align patent (ClinCheck Live Update).
- regulatorUS International Trade Commission (ITC)
Conducted an evidentiary hearing on five Align patents, with an initial determination expected in November 2026.
